© The Author 2005. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org
Correspondence |
Stepping-down inhaled corticosteroid therapy in stable asthma: a secondary care perspective
| The first 10% of the full text of this article appears below. |
Sir,
Stepping-down inhaled corticosteroid (ICS) therapy in stable asthmatics is often poorly implemented, albeit against a background of limited evidence.1 It is well established in the Global Initiative for Asthma (GINA) guidelines,2 and has recently been adopted by the British Thoracic Society and Scottish Intercollegiate Guidelines Network consortium.1 In the latter guidelines, it is recommended that a 2550% ICS
Department of Respiratory Medicine Ipswich Hospital Heath Road Ipswich email: dkclee@doctors.org.uk
Department of Respiratory Medicine Aberdeen Royal Infirmary Foresterhill Aberdeen
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Papi, G. Caramori, I. M. Adcock, and P. J. Barnes Rescue Treatment in Asthma: More Than As-Needed Bronchodilation Chest, June 1, 2009; 135(6): 1628 - 1633. [Abstract] [Full Text] [PDF] |
||||
